Financial Partners Group (Kansas)’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-2,209
Closed -$413K 89
2019
Q4
$413K Hold
2,209
0.16% 50
2019
Q3
$393K Sell
2,209
-725
-25% -$157K 0.17% 52
2019
Q2
$764K Sell
2,934
-6
-0.2% -$1.59K 0.36% 39
2019
Q1
$840K Buy
2,940
+31
+1% +$10.3K 0.45% 40
2018
Q4
$946K Sell
2,909
-256
-8% -$88.9K 0.62% 34
2018
Q3
$1.42M Buy
3,165
+552
+21% +$218K 0.93% 25
2018
Q2
$1.07M Buy
2,613
+498
+24% +$180K 0.78% 29
2018
Q1
$615K Buy
+2,115
New +$536K 0.48% 42

Other funds holding ABMD

Financial Partners Group (Kansas)'s ABMD Position: Q1 2020 in Review

Financial Partners Group (Kansas) sold out of Abiomed Inc (ABMD) in Q1 2020, closing a stake of 2,209 shares — an estimated $413K sold.

Financial Partners Group (Kansas) first reported a position in ABMD in Q1 2018 and held it in 8 quarters. The position peaked at $1.42M in Q3 2018. 412 funds tracked by Wall St. Rank hold ABMD as of Q1 2020.

  • Financial Partners Group (Kansas) reported no remaining Abiomed Inc position as of Q1 2020 after selling out during the quarter.
  • Financial Partners Group (Kansas) sold 2,209 Abiomed Inc shares in Q1 2020, an estimated $413K.
  • Financial Partners Group (Kansas) first reported a position in Abiomed Inc in Q1 2018 and held it in 8 quarters.
  • Financial Partners Group (Kansas)'s Abiomed Inc position peaked at $1.42M in Q3 2018.
  • 412 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2020.

Based on Financial Partners Group (Kansas)'s 13F filing for Q1 2020, filed 14 May 2020.